What Has Been the Growth of the Antiemetics And Antinauseants Market So Far?
The antiemetics and antinauseants market has seen considerable growth due to a variety of factors.
• The market for antiemetics and antinauseants has witnessed consistent growth in the previous years. Its size is projected to expand from $8.11 billion in 2024 to $8.45 billion in 2025, with a compound annual growth rate (CAGR) of 4.3%.
Factors such as established branding and market competition, traditional treatment preferences, the state of the economy, prior global health incidents, and advancements in medical research and technology are credited for this growth during the historic phase.
What Can Be Expected from the Antiemetics And Antinauseants Market in the Coming Years?
The antiemetics and antinauseants market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the market for antiemetics and antinauseants is projected to maintain a stable growth, reaching a valuation of $9.7 billion by 2029 with a CAGR of 3.5%.
This expected growth over the forecast period can be linked to efforts in research and development, economic conditions, competition within the market and prevailing industry trends, alterations in disease incidence, and healthcare policies and regulations. Noteworthy trends during this forecast period include a heightened emphasis on patient experience, shifts in healthcare policies, a consumer inclination towards non-invasive procedures, a surge in nausea cases related to chemotherapy and pregnancy, and the advent of tailored therapies.
What Key Factors and Trends are Driving the Growth of the Antiemetics And Antinauseants Market?
The growth of the antiemetics and antinauseants market is propelled by the rising frequency of cancer. Chemotherapy is frequently prescribed as a cancer treatment, and chemotherapy-induced nausea and vomiting (CINV) are common side effects of this treatment strategy. Antiemetics have proven effective in preventing CINV in approximately 60%-70% of patients. For example, The American Cancer Society, a US-based non-profit organization, predicted approximately 609,000 cancer-related fatalities and anticipated 1.9 million new instances of cancer in the country in 2022, as of April 2024. Around 620,000 cancer-related deaths are expected, indicating a slight increase in death rates in 2024. The escalating prevalence of cancer is expected to bolster the demand for antiemetics and antinauseants, subsequently fuelling market revenue.
How Are The Segments Defined Within The Global Antiemetics And Antinauseants Market?
The antiemetics and antinauseants market covered in this report is segmented –
1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types
2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types
3) By End Users: Hospital, Medical Center, Clinic, Research Institutes
Subsegments:
1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone
2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant
3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine
4) By Cannabinoids: Dronabinol, Nabilone
5) By Benzodiazepines: Lorazepam, Diazepam
6) By Anticholinergics: Scopolamine, Glycopyrrolate
7) By Steroids: Dexamethasone, Methylprednisolone
8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron
9) By Other Drug Types: Herbal Remedies, Acupressure Devices
Pre-Book The Antiemetics And Antinauseants Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Expected To Influence The Growth Of The Antiemetics And Antinauseants Market?
Leading firms in the antiemetic and antinauseant sector are focusing on innovative product development, such as ready-made injectable solutions, to simplify the treatment process and improve patient adherence. These pre-prepared formulations are created to deliver immediate efficacy, minimizing the time and intricacy linked with conventional injectable medications. For example, in July 2024, Amneal Pharmaceuticals, an American specialty pharmaceutical enterprise, introduced FOCINVEZ, the inaugural ready-to-use injectable variant of fosaprepitant, aimed at preventing the onset of acute and delayed nausea and vomiting linked with highly emetogenic cancer chemotherapy. The product, free from Polysorbate 80 and needing no reconstitution or dilution, is available as a 150 mg/50 mL vial and can be directly administered. FOCINVEZ is sanctioned for usage in adults and pediatric patients aged over six months and possesses a distinct J-Code (J1434) for reimbursement purposes.
Who Are the Key Players in the Antiemetics And Antinauseants Market?
Major companies operating in the antiemetics and antinauseants market include:
• Pfizer Inc.
• Johnson & Johnson Services Inc.
• Merck & Co. Inc.
• Bayer AG
• Novartis AG
• Sanofi SA
• AstraZeneca plc
• Abbott Laboratories
• GlaxoSmithKline plc
• Cipla Ltd.
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd.
• Baxter International Inc.
• Teva Pharmaceutical Industries Ltd.
• Astellas Pharma Inc.
• Kyowa Hakko Kirin Pharma Co. Ltd.
• Daiichi Sankyo Company
• Braun GmbH
• Eisai Co. Ltd.
• Sun Pharmaceuticals Industries Ltd.
• Dr. Reddy's Laboratories
• Hikma Pharmaceuticals plc
• IPCA Laboratories Ltd.
• Eagle Pharmaceuticals Inc.
• Cadila Pharmaceuticals Ltd.
• Bristol Laboratories Ltd.
• Tesaro Inc.
• SRS Pharmaceuticals Pvt. Ltd.
• Acacia Pharma Ltd.
• Algen Healthcare Ltd.
• Mirabilia Sciences Pvt. Ltd.
• Helsinn Healthcare SA
What Is The Most Dominant Region In The Antiemetics And Antinauseants Market?
North America was the largest region in the drugs for antiemetics and antinauseants market in 2024. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
